{"publication_identifier":{"eissn":["1476-4687"],"issn":["0028-0836"]},"month":"01","date_published":"2023-01-04T00:00:00Z","article_processing_charge":"Yes (in subscription journal)","publication_status":"published","publisher":"Springer Nature","author":[{"last_name":"Bravo","first_name":"Jack Peter Kelly","full_name":"Bravo, Jack Peter Kelly","orcid":"0000-0003-0456-0753","id":"96aecfa5-8931-11ee-af30-aa6a5d6eee0e"},{"last_name":"Hallmark","first_name":"Thomson","full_name":"Hallmark, Thomson"},{"full_name":"Naegle, Bronson","first_name":"Bronson","last_name":"Naegle"},{"last_name":"Beisel","first_name":"Chase L.","full_name":"Beisel, Chase L."},{"full_name":"Jackson, Ryan N.","first_name":"Ryan N.","last_name":"Jackson"},{"last_name":"Taylor","first_name":"David W.","full_name":"Taylor, David W."}],"oa_version":"Published Version","external_id":{"pmid":["36599980"]},"language":[{"iso":"eng"}],"page":"582-587","publication":"Nature","_id":"15130","status":"public","day":"04","date_created":"2024-03-20T10:41:36Z","scopus_import":"1","user_id":"2DF688A6-F248-11E8-B48F-1D18A9856A87","volume":613,"oa":1,"abstract":[{"lang":"eng","text":"Cas12a2 is a CRISPR-associated nuclease that performs RNA-guided, sequence-nonspecific degradation of single-stranded RNA, single-stranded DNA and double-stranded DNA following recognition of a complementary RNA target, culminating in abortive infection1. Here we report structures of Cas12a2 in binary, ternary and quaternary complexes to reveal a complete activation pathway. Our structures reveal that Cas12a2 is autoinhibited until binding a cognate RNA target, which exposes the RuvC active site within a large, positively charged cleft. Double-stranded DNA substrates are captured through duplex distortion and local melting, stabilized by pairs of ‘aromatic clamp’ residues that are crucial for double-stranded DNA degradation and in vivo immune system function. Our work provides a structural basis for this mechanism of abortive infection to achieve population-level immunity, which can be leveraged to create rational mutants that degrade a spectrum of collateral substrates."}],"quality_controlled":"1","issue":"7944","year":"2023","article_type":"original","pmid":1,"intvolume":" 613","extern":"1","title":"RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2","type":"journal_article","doi":"10.1038/s41586-022-05560-w","citation":{"ista":"Bravo JPK, Hallmark T, Naegle B, Beisel CL, Jackson RN, Taylor DW. 2023. RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2. Nature. 613(7944), 582–587.","short":"J.P.K. Bravo, T. Hallmark, B. Naegle, C.L. Beisel, R.N. Jackson, D.W. Taylor, Nature 613 (2023) 582–587.","chicago":"Bravo, Jack Peter Kelly, Thomson Hallmark, Bronson Naegle, Chase L. Beisel, Ryan N. Jackson, and David W. Taylor. “RNA Targeting Unleashes Indiscriminate Nuclease Activity of CRISPR–Cas12a2.” Nature. Springer Nature, 2023. https://doi.org/10.1038/s41586-022-05560-w.","mla":"Bravo, Jack Peter Kelly, et al. “RNA Targeting Unleashes Indiscriminate Nuclease Activity of CRISPR–Cas12a2.” Nature, vol. 613, no. 7944, Springer Nature, 2023, pp. 582–87, doi:10.1038/s41586-022-05560-w.","apa":"Bravo, J. P. K., Hallmark, T., Naegle, B., Beisel, C. L., Jackson, R. N., & Taylor, D. W. (2023). RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2. Nature. Springer Nature. https://doi.org/10.1038/s41586-022-05560-w","ieee":"J. P. K. Bravo, T. Hallmark, B. Naegle, C. L. Beisel, R. N. Jackson, and D. W. Taylor, “RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2,” Nature, vol. 613, no. 7944. Springer Nature, pp. 582–587, 2023.","ama":"Bravo JPK, Hallmark T, Naegle B, Beisel CL, Jackson RN, Taylor DW. RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2. Nature. 2023;613(7944):582-587. doi:10.1038/s41586-022-05560-w"},"date_updated":"2024-06-04T06:30:59Z","main_file_link":[{"url":"https://doi.org/10.1038/s41586-022-05560-w","open_access":"1"}]}